Carisma Therapeutics Inc.

AI Score

0

Unlock

0.44
-0.01 (-3.25%)
At close: Jan 15, 2025, 1:46 PM

Carisma Therapeutics Inc. Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for CARM stock have an median target of 6.5, with a low estimate of 0.7 and a high estimate of 24. The median target predicts an increase of 1377.27% from the current stock price of 0.44.

Analyst Consensus: Hold
Target Low Average Median High
Price $0.7 $9.43 $6.5 $24
Change 59.09% 2043.18% 1377.27% 5354.55%

AI Analyst Report

D. Boral Capital has reaffirmed a Buy rating for C... Unlock content with Pro Subscription

Updated Jan 13, 2025

Rating May 24Jun 24Oct 24Nov 24Dec 24Jan 25
Strong Buy 000000
Buy 221421
Hold 000040
Sell 000000
Strong Sell 000000
Total 2 2 1 4 6 1

Financial Forecast this Year

Revenue This Year
21.41M
from 14.92M
Increased by 43.5%
Revenue Next Year
20.32M
from 21.41M
Increased by -5.1%
EPS This Year
-1.21
from -2.59
Increased by 53.3%
EPS Next Year
-0.53
from -1.21
Increased by 56.2%